Morepen Laboratories Ltd.

NSE: MOREPENLAB | BSE: 500288

Mid-range Performer

Download real time

59.26 -0.91 (-1.51%)

41.27% Fall from 52W High

7.0M NSE+BSE Volume

NSE 02 May, 2025 3:31 PM (IST)

3,247.2

Market Cap

Above industry Median

1.6

Beta 1Year

Very High Volatility

Morepen Laboratories Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Morepen Laboratories Ltd. from all sources in a single place.

Load latest

Morepen Laboratories Ltd.

14 Jan 2025

59.26

-1.51%

Company Update

MOREPEN LABORATORIES LTD. - 500288 - Outcome Of Board Meeting-Hiving Off Medical Devices Business

BSE India

Please find attached outcome of Board Meeting.

Morepen Laboratories Ltd.

08 Jan 2025

59.26

-1.51%

Company Update

MOREPEN LABORATORIES LTD. - 500288 - Intimation Under Regulation 30 Of Incorporation Of A Subsidiary Company.

BSE India

Intimation of Incorporation of a subsidiary company.

Morepen Laboratories Ltd.

30 Dec 2024

59.26

-1.51%

SAST

MOREPEN LABORATORIES LTD. - 500288 - Closure of Trading Window

BSE India

Intimation of closure of Trading Window

Morepen Laboratories Ltd.

27 Dec 2024

59.26

-1.51%

Corp. Note

MOREPEN LABORATORIES LTD. - 500288 - Disclosure under Regulation 30A of LODR

BSE India

Incorporation of a new subsidiary company.

Morepen Laboratories Ltd.

18 Dec 2024

59.26

-1.51%

Company Update

MOREPEN LABORATORIES LTD. - 500288 - Loan Agreement

BSE India

Please find attached intimation

Morepen Laboratories Ltd.

14 Dec 2024

59.26

-1.51%

Dr Morepen Eyes Rs 500-Crore Revenue From Wellness Business In Four Years

NDTV Profit

Dr Morepen has entered into the wellness segment with the launch of a new weight management programme aimed at addressing the issue of obesity.

Morepen Laboratories Ltd. is trading above its 50 day SMA of 50.9

Morepen Laboratories Ltd.

11 Dec 2024

59.26

-1.51%

Dr Morepen launches weight management product, forays into wellness biz

Business Standard

Company eyes Rs 30 crore revenue in first year, Rs 200 crore by 2030

Morepen Laboratories Ltd. has gained 20.01% in the last 1 Month

Dr. Morepen eyes Rs 100 crore revenue in next three years from this weight loss product

Business Today | 10 Dec 2024 1 more

Morepen Laboratories Ltd.

10 Dec 2024

59.26

-1.51%

Company Update

MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Please find attached press release.

Morepen Laboratories Ltd.

10 Dec 2024

59.26

-1.51%

Dr Morepen forays into wellness segment with weight management initiative

Business Standard

Dr Morepen on Tuesday forayed into the growing wellness segment with the launch of a weight management initiative. The company, a fully-owned subsidiary of Morepen Laboratories, is looking to establish itself in the segment which is currently valued at around Rs 12,000 crore and growing at an annual rate of 16 per cent. The company has launched its wellness product -- LightLife -- designed to tackle India's growing obesity crisis. India's obesity rate is increasing and this segment is expected to touch USD 52.3 billion by 2032, "reflecting the urgency to address weight management with solutions that are both safe and effective," Dr Morepen CEO Varun Suri said. With LightLife the company is looking to address the obesity issue without crash diets or harmful fads, he stated. According to the World Obesity Atlas 2024, over 25 per cent of Indian adults are projected to face obesity by 2035. Suri said the company's initiative is about promoting a healthy balanced lifestyle through...

Morepen Laboratories Ltd. has lost -26.69% in the last 6 Months

Morepen Laboratories Ltd.

04 Dec 2024

59.26

-1.51%

Corp. Note

MOREPEN LABORATORIES LTD. - 500288 - Disclosure under Regulation 30A of LODR

BSE India

Please find enclosed file.

Is Morepen Laboratories Ltd. worth buying?

755 Votes:

Buy 81.72%

Sell 8.21%

Hold 10.07%